Want to see how your resume matches up to this job? A free trial of our JobsAI will help! With over 2,000 biopharma executives loving it, we think you will too! Try it now — JobsAI.
The Summer 2026 Statistical Genetics Intern will leverage advanced statistical genetics approaches to prioritize potential drug targets for less common neurologic diseases, including dementia with Lewy bodies, Frontotemporal dementia, ALS, and related neuro traits such as sleep disturbance. The intern will perform Mendelian randomization and colocalization analyses using publicly available GWAS summary statistics for disease risk and cerebrospinal fluid (CSF) proteomics to identify putative causal genes. Additionally, the role involves utilizing large language models (LLMs) to further refine and prioritize genetically supported targets by evaluating their relevance to disease-specific biological functions and informing experimental validation strategies. This full-time internship will take place June - August 2026.